Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-19

Clinical Trial Update: Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach [Phase 4]

View source ↗

Summary

Phase 4 trial investigating cyclical neuroactive steroid changes, arousal, and proximal suicidal ideation. Results have been posted (2025-12-19).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Experimental neuroactive steroid regimen

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Suicidal Ideation | Phase 4 | Status: COMPLETED | Results posted: 2025-12-19